Despite a ban received in February 2022 from the FDA (Food and Drug Administration) on brain chip testing in humans, Elon Musk previously announced a positive decision in the spring. However, Neuralink has denied a request to start human trials.

This was reported by Reuters.

The FDA explains the waiver as a security issue. As you know, testing the BCI (brain-computer interface) chips on animals showed that the test subjects suffered and died.

From the testimony of current and former Neuralink employees, it follows that the danger is related to the device’s lithium battery. There is the possibility of “migrating tiny implant wires to other areas of the brain.” Also, the question “is it possible and how exactly to remove the device without damaging the brain tissue” has not been resolved, the agency informs.

Commentary